Skip to Content

cnn-other

India's homegrown Covid-19 vaccine has 78% efficacy against symptomatic infections

India’s homegrown Covid-19 vaccine has 78% efficacy against symptomatic infections, developer says

By Manveena Suri and Julia Hollingsworth, CNN India’s homegrown Covid-19 vaccine Covaxin has an efficacy rate of more than 93.4% against severe Covid-19 infection and 77.8% against symptomatic infection, according to data released Saturday by the shot’s developer. Pharmaceutical company Bharat Biotech announced it had concluded the final analysis of its Phase 3 clinical trials,

Continue Reading
Skip to content